The estimated Net Worth of Thomas F Kirk is at least 965 千$ dollars as of 29 May 2024. Thomas Kirk owns over 50,000 units of Myomo Inc stock worth over 964,916$ and over the last 7 years Thomas sold MYO stock worth over 0$.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Thomas Kirk MYO stock SEC Form 4 insiders trading
Thomas has made over 4 trades of the Myomo Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Thomas bought 50,000 units of MYO stock worth 175,000$ on 29 May 2024.
The largest trade Thomas's ever made was buying 50,000 units of Myomo Inc stock on 29 May 2024 worth over 175,000$. On average, Thomas trades about 10,964 units every 112 days since 2017. As of 29 May 2024 Thomas still owns at least 236,499 units of Myomo Inc stock.
You can see the complete history of Thomas Kirk stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Thomas Kirk's mailing address?
Thomas's mailing address filed with the SEC is C/O MYOMO, INC., 137 PORTLAND ST., 4TH FLOOR, BOSTON, MA, 02114.
Insiders trading at Myomo Inc
Over the last 7 years, insiders at Myomo Inc have traded over 203,224$ worth of Myomo Inc stock and bought 776,898 units worth 937,925$ . The most active insiders traders include Steve Sanghi、Paul R Gudonis、Heather C Getz. On average, Myomo Inc executives and independent directors trade stock every 57 days with the average trade being worth of 120,686$. The most recent stock trade was executed by Harry Kovelman on 5 September 2024, trading 6,700 units of MYO stock currently worth 25,192$.
What does Myomo Inc do?
myomo's mission is to enable individuals to overcome their paralysis by providing innovative, myoelectric orthotics and support services. we are committed to working with healthcare professionals to deliver high quality outcomes and patient satisfaction through research collaborations and continuing education programs. the company empowers persons with a neuromuscular disability to perform functional activities at home, at work, and in the community, resulting in an improved quality of life and lower healthcare costs.
What does Myomo Inc's logo look like?
Complete history of Thomas Kirk stock trades at Myomo Inc
Myomo Inc executives and stock owners
Myomo Inc executives and other stock owners filed with the SEC include:
-
Paul R. Gudonis,
Chairman, Pres & CEO -
David A. Henry,
Chief Financial Officer -
Micah J. Mitchell,
Chief Commercial Officer -
Jonathan Naft,
VP & GM -
Fredrick Nahm,
Medical Director -
Jonathan Naft,
General Manager - O&P -
David Henry,
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer -
Paul Gudonis,
Chief Executive Officer, Director -
Steve Kelly,
Founder, Chairman of the Board, President and Chief Operating Officer -
Dr. Harry Kovelman M.D.,
Chief Medical Officer -
Clifford J. Conneighton,
Chief Marketing Officer -
Thomas F Kirk,
-
Ralph A Goldwasser,
Chief Financial Officer -
Steve Sanghi,
Director -
Cliff Conneighton,
Chief Marketing Officer -
Micah Mitchell,
Chief Commercial Officer -
Davie Mendelsohn,
VP, Sales -
Brandon M Green,
Chief Medical Officer -
Thomas Aloysius Jr. Crowley,
-
Milton Mayo Morris,
-
Harry Kovelman,
Chief Medical Officer -
Amy K. Knapp,
-
Heather C Getz,